{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:58:56Z","timestamp":1790261936292,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T00:00:00Z","timestamp":1570233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T00:00:00Z","timestamp":1570233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"the National S&T Major Project","award":["2017ZX10203205"],"award-info":[{"award-number":["2017ZX10203205"]}]},{"name":"the Foundation for Zhejiang Medical and Health Science and Technology Project","award":["2018KY376"],"award-info":[{"award-number":["2018KY376"]}]},{"DOI":"10.13039\/501100001809","name":"the National\u2002Natural\u2002Science\u2002Foundation\u2002of\u2002China","doi-asserted-by":"crossref","award":["81902407"],"award-info":[{"award-number":["81902407"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10620-019-05844-8","type":"journal-article","created":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T05:02:46Z","timestamp":1570251766000},"page":"1064-1073","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Ubiquitin-Specific Protease 22\/Silent Information Regulator 1 Axis Plays a Pivotal Role in the Prognosis and 5-Fluorouracil Resistance in Hepatocellular Carcinoma"],"prefix":"10.1007","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9190-2752","authenticated-orcid":false,"given":"Xue","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunbin","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaonan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,5]]},"reference":[{"key":"5844_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin."},{"key":"5844_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/hep.27388","volume":"61","author":"B Njei","year":"2015","unstructured":"Njei B, Rotman Y, Ditah I, Lim JK. Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology. 2015;61:191\u2013199.","journal-title":"Hepatology"},{"key":"5844_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/hepr.12548","volume":"46","author":"T Chiba","year":"2016","unstructured":"Chiba T, Iwama A, Yokosuka O. Cancer stem cells in hepatocellular carcinoma: therapeutic implications based on stem cell biology. Hepatol Res. 2016;46:50\u201357.","journal-title":"Hepatol Res."},{"key":"5844_CR4","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.3748\/wjg.v20.i8.2098","volume":"20","author":"Z Guo","year":"2014","unstructured":"Guo Z, Li LQ, Jiang JH, Ou C, Zeng LX, Xiang BD. Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma. World J Gastroenterol. 2014;20:2098\u20132106.","journal-title":"World J Gastroenterol."},{"key":"5844_CR5","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1146\/annurev.biochem.78.082307.091526","volume":"78","author":"FE Reyes-Turcu","year":"2009","unstructured":"Reyes-Turcu FE, Ventii KH, Wilkinson KD. Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu Rev Biochem. 2009;78:363\u2013397.","journal-title":"Annu Rev Biochem."},{"key":"5844_CR6","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.2147\/OTT.S148662","volume":"11","author":"X Yang","year":"2018","unstructured":"Yang X, Zang H, Luo Y, et al. High expression of USP22 predicts poor prognosis and advanced clinicopathological features in solid tumors: a meta-analysis. Onco Targets Ther. 2018;11:3035\u20133046.","journal-title":"Onco Targets Ther."},{"key":"5844_CR7","first-page":"2040","volume":"17","author":"T Liu","year":"2019","unstructured":"Liu T, Liu J, Chen Q, et al. Expression of USP22 and the chromosomal passenger complex is an indicator of malignant progression in oral squamous cell carcinoma. Oncol Lett. 2019;17:2040\u20132046.","journal-title":"Oncol Lett"},{"key":"5844_CR8","first-page":"L1803","volume":"58","author":"SB Ling","year":"2012","unstructured":"Ling SB, Sun DG, Tang B, et al. Knock-down of USP22 by small interfering RNA interference inhibits HepG2 cell proliferation and induces cell cycle arrest. Cell Mol Biol (Noisy-le-grand). 2012;58:L1803\u2013L1808.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"5844_CR9","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1128\/MCB.00971-12","volume":"33","author":"SM Armour","year":"2013","unstructured":"Armour SM, Bennett EJ, Braun CR, et al. A high-confidence interaction map identifies SIRT1 as a mediator of acetylation of USP22 and the SAGA coactivator complex. Mol Cell Biol. 2013;33:1487\u20131502.","journal-title":"Mol Cell Biol."},{"key":"5844_CR10","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3892\/ol.2015.3982","volume":"11","author":"DF Yu","year":"2016","unstructured":"Yu DF, Jiang SJ, Pan ZP, et al. Expression and clinical significance of Sirt1 in colorectal cancer. Oncol Lett. 2016;11:1167\u20131172.","journal-title":"Oncol Lett."},{"key":"5844_CR11","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1080\/00313020902884451","volume":"41","author":"KY Jang","year":"2009","unstructured":"Jang KY, Kim KS, Hwang SH, et al. Expression and prognostic significance of SIRT1 in ovarian epithelial tumours. Pathology. 2009;41:366\u2013371.","journal-title":"Pathology"},{"key":"5844_CR12","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3892\/ol.2015.3914","volume":"11","author":"SY Lin","year":"2016","unstructured":"Lin SY, Peng F. Association of SIRT1 and HMGA1 expression in non-small cell lung cancer. Oncol Lett. 2016;11:782\u2013788.","journal-title":"Oncol Lett."},{"key":"5844_CR13","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1038\/onc.2016.521","volume":"36","author":"H Xiong","year":"2017","unstructured":"Xiong H, Ni Z, He J, et al. LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells. Oncogene. 2017;36:3528\u20133540.","journal-title":"Oncogene"},{"key":"5844_CR14","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.molcel.2012.03.024","volume":"46","author":"Z Lin","year":"2012","unstructured":"Lin Z, Yang H, Kong Q, et al. USP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic development. Mol Cell. 2012;46:484\u2013494.","journal-title":"Mol Cell"},{"key":"5844_CR15","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/1878-0261.12067","volume":"11","author":"S Ling","year":"2017","unstructured":"Ling S, Li J, Shan Q, et al. USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1\/AKT\/MRP1 signaling pathway. Mol Oncol. 2017;11:682\u2013695.","journal-title":"Mol Oncol"},{"key":"5844_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1128\/MCB.26.1.28-38.2006","volume":"26","author":"JM Solomon","year":"2006","unstructured":"Solomon JM, Pasupuleti R, Xu L, et al. Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. Mol Cell Biol. 2006;26:28\u201338.","journal-title":"Mol Cell Biol."},{"key":"5844_CR17","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.4161\/cc.7.11.5962","volume":"7","author":"XY Zhang","year":"2008","unstructured":"Zhang XY, Pfeiffer HK, Thorne AW, McMahon SB. USP22, an hSAGA subunit and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2A. Cell Cycle. 2008;7:1522\u20131524.","journal-title":"Cell Cycle"},{"key":"5844_CR18","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.3892\/ijo.2015.3214","volume":"47","author":"B Tang","year":"2015","unstructured":"Tang B, Liang X, Tang F, et al. Expression of USP22 and Survivin is an indicator of malignant behavior in hepatocellular carcinoma. Int J Oncol. 2015;47:2208\u20132216.","journal-title":"Int J Oncol"},{"key":"5844_CR19","doi-asserted-by":"crossref","first-page":"12654","DOI":"10.18632\/oncotarget.3705","volume":"6","author":"B Tang","year":"2015","unstructured":"Tang B, Tang F, Li B, et al. High USP22 expression indicates poor prognosis in hepatocellular carcinoma. Oncotarget. 2015;6:12654\u201312667.","journal-title":"Oncotarget"},{"key":"5844_CR20","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1007\/s13277-015-3488-x","volume":"36","author":"Y Wu","year":"2015","unstructured":"Wu Y, Meng X, Huang C, Li J. Emerging role of silent information regulator 1 (SIRT1) in hepatocellular carcinoma: a potential therapeutic target. Tumour Biol. 2015;36:4063\u20134074.","journal-title":"Tumour Biol"},{"key":"5844_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.toxlet.2018.03.011","volume":"289","author":"MP Ceballos","year":"2018","unstructured":"Ceballos MP, Decandido G, Quiroga AD, et al. Inhibition of sirtuins 1 and 2 impairs cell survival and migration and modulates the expression of P-glycoprotein and MRP3 in hepatocellular carcinoma cell lines. Toxicol Lett. 2018;289:63\u201374.","journal-title":"Toxicol Lett."},{"key":"5844_CR22","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.3892\/ol.2013.1188","volume":"5","author":"ZH Li","year":"2013","unstructured":"Li ZH, Yu Y, Du C, Fu H, Wang J, Tian Y. RNA interference-mediated USP22 gene silencing promotes human brain glioma apoptosis and induces cell cycle arrest. Oncol Lett. 2013;5:1290\u20131294.","journal-title":"Oncol Lett."},{"key":"5844_CR23","doi-asserted-by":"publisher","first-page":"891","DOI":"10.2147\/OTT.S154754","volume":"11","author":"Z Shen","year":"2018","unstructured":"Shen Z, Yu X, Zheng Y, et al. CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker. Onco Targets Ther. 2018;11:891\u2013901.","journal-title":"Onco Targets Ther"},{"key":"5844_CR24","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1159\/000489156","volume":"46","author":"S Jiang","year":"2018","unstructured":"Jiang S, Song C, Gu X, et al. Ubiquitin-Specific peptidase 22 contributes to colorectal cancer Stemness and chemoresistance via Wnt\/beta-Catenin pathway. Cell Physiol Biochem. 2018;46:1412\u20131422.","journal-title":"Cell Physiol Biochem."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05844-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-019-05844-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05844-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T23:19:08Z","timestamp":1601767148000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-019-05844-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,5]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["5844"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-05844-8","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,5]]},"assertion":[{"value":"3 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the ethics committee of the First Affiliated Hospital of Zhejiang University and performed in accordance with the ethical guidelines denoted in the Declaration of Helsinki (version 2013). Since this is a retrospective analysis, the requirement of a written informed consent was waived by the ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}